Back to Search
ALESSANDRO TESTORI, MD PHD
MD PHD
Internal Medicine Physician
NPI: 1326057050IndividualAccepts Medicare
Education
OTHER
Class of 2003
Research & Publications (20)
Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
PMID 19132446·Ann Surg Oncol·2009
3-trial
Surgery and radiotherapy in the treatment of cutaneous melanoma.
PMID 19617294·Ann Oncol·2009
6-review
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.
PMID 18620949·Lancet·2008
3-trial
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
PMID 18281670·J Clin Oncol·2008
3-trial
The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients.
PMID 15917701·Melanoma Res·2005
4-observational
Diagnosis of melanoma in the elderly and surgical implications.
PMID 15615659·Surg Oncol·2004
6-review
Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia.
PMID 19448678·Bone Marrow Transplant·2010
8-other
Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).
PMID 19621225·Cancer Chemother Pharmacol·2010
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1551 PROFESSIONAL LN UNIT 170
LONGMONT, CO 80501 - Phone
- (303) 776-0868
Quick Facts
- NPI
- 1326057050
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile